CareDx Reports Fourth Quarter and Full Year 2021 Results

Go back to CareDx Reports Fourth Quarter and Full Year 2021 Results

CareDx (CDNA) Misses Q4 EPS by 6c

February 24, 2022 4:27 PM EST

CareDx (NASDAQ: CDNA) reported Q4 EPS of ($0.03), $0.06 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $79.2 million versus the consensus estimate of $78.09 million.

GUIDANCE:

CareDx sees FY2022 revenue of $330-350 million, versus the consensus of $343... More